Anticancer agent 7

Overview

Anticancer agent 7 (Example 5) modulates PP2A , and induces FOXOl transcription factor translocation to the nucleus. Anticancer agent 7 inhibits the proliferation of H1650 lung cancer cell with an IC 50 of 5 μM.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Phosphatase | Products > Signaling Pathways > FOXO

Product Information

• Catalog No.: HY-W072940
• CAS No.: 2088956-21-0
• Molecular Formula: C24H19Cl2F3N2O5S
• Molecular Weight: 575.38
• Purity: 97.01%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (4.34 mM); Clear solution
• Availability: In-stock

Source

Original product source